Log in
Enquire now
‌

US Patent 11390674 Anti-TIM-3 antibodies and compositions

Patent 11390674 was granted and assigned to Symphogen on July, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
‌
Symphogen
Date Filed
April 11, 2017
Date of Patent
July 19, 2022
Patent Applicant
‌
Symphogen
Patent Application Number
16093024
Patent Citations
‌
US Patent 10550181 Anti-TIM-3 antibody
0
Patent Citations Received
‌
US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3
0
Patent Inventor Names
Torben Gjetting
0
Trine Lindsted
0
Gunther Roland Galler
0
Ivan David Horak
0
Klaus Koefoed
0
Michael Kragh
0
Michael Monrad Grandal
0
Mikkel Wandahl Pedersen
0
Monika Gad
0
Thomas Bouquin
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11390674
Patent Primary Examiner
‌
Mark Halvorson

Find more entities like US Patent 11390674 Anti-TIM-3 antibodies and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.